A retrospective study ofsimultaneous pancreas-kidney transplantation from a single-center experience
10.3760/cma.j.issn.0254-1785.2019.05.002
- VernacularTitle:胰肾联合移植145例单中心回顾分析
- Author:
Yingxin FU
1
;
Hui WANG
;
Gang FENG
;
Wenli SONG
;
Chunbai MO
;
Xiaofeng SHI
;
Zhen WANG
;
Yu CAO
;
Jie ZHAO
;
Zhongyang SHEN
Author Information
1. 天津市第一中心医院 300192
- Keywords:
Simultaneous pancreas-kidney transplantation;
Operative indication;
Surgical techniques;
Graft loss;
Risk factor;
Complication;
Prevention
- From:
Chinese Journal of Organ Transplantation
2019;40(5):260-265
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the surgical indications for pancreas-kidney surgery and summarize the experiences of ,selecting surgical approaches ,formulating immunosuppressive regimens and preventing complications .Methods A total of 145 donor simultaneous pancreas-kidney transplants in uremic patients with T1DM/T2DM between 2002 and 2018 were retrospectively analyzed .Based upon surgical approaches and immunosuppressive agents ,they were divided into three eras of 2002-2010 ,2011-2014 and 2015-2018 respectively .Patient profiles ,survival outcomes of patient and graft , surgical techniques ,immunosuppressive agents and incidence of common complications were compared among different groups .Results The overall 1/3/5-year patient and graft survival rates of three groups were above 75％ and the survival rates of group Ⅰ were inferior to those of groups Ⅱ and Ⅲ(P<0 .001) .The overall 1/3/5-year pancreas graft survival rates were the highest in group Ⅲ and the lowest in group Ⅱ (P=0 .004) .In the 2015-2018 group ,ipsilateral pancreas-kidney transplantation and SE-ED surgery were more preferred .Regarding the incidence of complications ,graft thrombosis frequently occurred from 2011 to 2014 and intestinal obstruction was more common from 2002 to 2010 .For univariable analysis of graft loss ,anticoagulation programme with argatroban monohydrate were 0 .28 times likely to lose pancreas graft (OR= 0 .28 ,95％ CI:0 .09-0 .86) and T1DM patients were 4 times likely to have kidney graft loss (OR=4 .08 ,95％ CI:1 .37-12 .15) .Conclusions SPK is an effective treatment for uremic diabetics . Effective perioperative management and preventing complications are crucial for prolonging patient and graft survivals .
